Eric Santoni Rugiu

Eric Santoni Rugiu

Clinical Associate Professor

Member of:

  • Pathology


  1. 2013
  2. Published

    IS RRM1 A PREDICTIVE MARKER FOR VINORELBINE EFFICACY - THE RESULTS FROM A COHORT OF MALIGNANT PLEURAL MESOTHELIOMAS TREATED WITH CISPLATIN AND VINORELBINE

    Zimling, Z. G., Santoni Rugiu, Eric, Bech, C. & Sørensen, Jens Benn, 2013, In: Journal of Thoracic Oncology.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Intratumour variation of biomarker expression by immunohistochemistry in resectable non-small cell lung cancer

    Jakobsen, J. N., Santoni Rugiu, Eric, Ravn, J. & Sørensen, Jens Benn, 2013, In: European journal of cancer (Oxford, England : 1990). 49, 11, p. 2494-2503 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Loss of miR-10a activates Lpo and collaborates with activated Wnt signaling in inducing intestinal Neoplasia in female mice

    Stadthagen Gomez, G., Tehler, D. E., Høyland-Kroghsbo, Nina Molin, Wen, J., Krogh, Anders, Jensen, K. T., Santoni Rugiu, Eric, Engelholm, Lars Henning & Lund, Anders H., 2013, In: P L o S Genetics. 9, 10, 12 p., e1003913.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    PRETREATMENT THYMIDYLATE SYNTHASE PROTEIN EXPRESSION LEVELS REMAINS STABLE DURING PACLITAXEL AND CARBOPLATIN TREATMENT IN NON-SMALL CELL LUNG CANCER

    Jakobsen, J. N., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2013, In: Journal of Thoracic Oncology.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Predictive impact of RRM1 protein expression on vinorelbine efficacy in NSCLC patients randomly assigned in a chemotherapy phase III trial

    Vilmar, A. C., Santoni Rugiu, Eric & Sørensen, Jens Benn, 2013, In: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 24, 2, p. 309-14 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published
  8. Published

    TARGETING HDACS TO OVERCOME CISPLATIN RESISTANCE IN MALIGNANT PLURAL MESOTHELIOMA

    Baird, A., Jennings, C. J., Mcdonagh, L., Flynn, L., Donnell, E. O., Barr, M., Santoni Rugiu, Eric, Hansen, F. K., Kurz, T., Takiguchi, Y., Thomas, W., Zimling, Z. G., O'Byrne, K. & Gray, S., 2013, In: Journal of Thoracic Oncology.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. 2012
  10. Published

    [Lack of uniformity in the treatment of thymomas].

    Santoni Rugiu, Eric, 1 Dec 2012, In: Ugeskrift for Laeger.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    A biomarker profile for predicting efficacy of cisplatin-vinorelbine therapy in malignant pleural mesothelioma

    Zimling, Z. G., Sørensen, Jens Benn, Gerds, Thomas Alexander, Bech, C., Andersen, C. B. & Santoni Rugiu, Eric, Nov 2012, In: Cancer Chemotherapy and Pharmacology. 70, 5, p. 743-54 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab

    Jensen, J. D., Knoop, A., Lænkholm, Anne-Vibeke, Grauslund, M., Jensen, M. B., Santoni Rugiu, Eric, Andersson, M. & Ewertz, M., Aug 2012, In: Annals of oncology : official journal of the European Society for Medical Oncology. 23, 8, p. 2034-2042 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1...4 5 6 7 8 9 10 11 ...15 Next

ID: 10801856